337362 Scale-Up and Operation of Continuous Hydrogenation in the Manufacturing Setting
337362 Scale-Up and Operation of Continuous Hydrogenation in the Manufacturing Setting
Thursday, November 7, 2013: 1:20 PM
Plaza B (Hilton)
Eli Lilly has been developing Continuous technologies for drug substance manufacure for several years. This technology is now being scaled up and transferred from the development setting to the manufacturing setting. The technical and operational considerations in scaling up a Continuous Hydrogenation in a manufacturing setting will be discussed. This includes operational, safety and robustness items aswell as technical scale-up issues.
See more of this Session: Pharmaceutical Manufacturing Post Launch: Process Improvements and Process Learning
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum

Google
Yelp
Facebook
Twitter
ChEnected